ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

RLAY Relay Therapeutics Inc

7.03
-0.06 (-0.85%)
18 Jun 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Relay Therapeutics Inc RLAY NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.06 -0.85% 7.03 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
7.05 7.00 7.58 7.03 7.09
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
12/6/202415:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202407:00EDGAR2Form 8-K - Current report
06/6/202406:00GLOBERelay Therapeutics Discloses Three New Programs at New..
05/6/202419:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/6/202419:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/6/202419:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/6/202419:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/6/202415:12EDGAR2Form 144 - Report of proposed sale of securities
05/6/202415:05GLOBERelay Therapeutics Announces Clinical Trial Collaboration..
04/6/202415:07EDGAR2Form 144 - Report of proposed sale of securities
03/6/202415:05EDGAR2Form 8-K - Current report
21/5/202415:05GLOBERelay Therapeutics to Participate in Upcoming Investor..
13/5/202407:30GLOBERelay Therapeutics to Host New Program and Platform Event on..
02/5/202415:05GLOBERelay Therapeutics Reports First Quarter 2024 Financial..
25/4/202415:05GLOBERelay Therapeutics to Announce First Quarter 2024 Financial..
11/4/202415:05GLOBERelay Therapeutics to Participate in Upcoming Investor..
26/2/202415:05GLOBERelay Therapeutics to Participate in Three Upcoming Investor..
22/2/202415:34EDGAR2Form S-8 - Securities to be offered to employees in employee..
22/2/202415:16EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
22/2/202415:10EDGAR2Form 8-K - Current report
22/2/202415:05GLOBERelay Therapeutics Reports Fourth Quarter and Full Year 2023..
15/2/202415:05GLOBERelay Therapeutics to Announce Fourth Quarter and Full Year..
01/2/202415:05GLOBERelay Therapeutics to Participate in the Guggenheim..
31/1/202415:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202415:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202415:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202415:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202415:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202408:22EDGAR2Form 424B7 - Prospectus [Rule 424(b)(7)]
10/1/202408:14EDGAR2Form D - Notice of Exempt Offering of Securities
08/1/202406:05EDGAR2Form 8-K - Current report
08/1/202406:00GLOBERelay Therapeutics Announces $30 Million Private Placement..
02/1/202415:05GLOBERelay Therapeutics to Present at 42nd Annual J.P. Morgan..
29/12/202315:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/12/202315:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/11/202315:16EDGAR2Form 424B7 - Prospectus [Rule 424(b)(7)]
07/11/202315:05GLOBERelay Therapeutics to Participate in Stifel 2023 Healthcare..
02/11/202315:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202315:10EDGAR2Form 8-K - Current report
02/11/202315:05GLOBERelay Therapeutics Reports Third Quarter 2023 Financial..
01/11/202315:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202315:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/10/202315:05GLOBERelay Therapeutics to Announce Third Quarter 2023 Financial..
12/10/202315:13EDGAR2Form 8-K - Current report
12/10/202315:05GLOBERelay Therapeutics Announces Initial RLY-4008..
29/9/202316:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/9/202315:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/9/202315:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/9/202315:05GLOBERelay Therapeutics to Present Clinical Data on RLY-4008 in..
08/8/202315:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Su Consulta Reciente

Delayed Upgrade Clock